MDMA and Sexual Behavior: Ecstasy Users' Perceptions About Sexuality and Sexual Risk

Recreational use of 3,4-methylenedioxymethamphetamine (MDMA, commonly called Ecstasy) expanded in the 1970s–1980s, and prior studies have reported mixed effects of the drug on sexuality. Some earlier work described increased sexual arousal and reports that MDMA functions as a sexual enhancer, while other studies—often involving frequent users or polydrug users—found diminished sexual interest or impaired sexual performance. Much of the existing literature is cross-sectional and conflated with use of other substances, making it difficult to establish whether sexual behaviours occurred specifically during MDMA episodes or reflected broader lifestyle patterns characterised by risk taking. Mcelrath set out to address these gaps using qualitative methods. The study aimed to (1) describe Ecstasy users' perceptions of the drug's effects on sensuality, sexuality, and sexual performance, and (2) examine sexual risk taking during episodes of MDMA use. Data were collected through in-depth interviews with current and former users in Northern Ireland to capture subjective accounts of drug effects and related sexual behaviours.

This was a qualitative study based on face-to-face, semi-structured interviews conducted between October 1997 and November 1998. Eligibility required any lifetime use of Ecstasy; the study team initially interviewed 106 people but excluded eight interviews for recording or transcription problems, yielding a final sample of 98 respondents. Mcelrath and colleagues used a purposive recruitment strategy that combined multiple approaches: announcements in shops and community venues, advertisements in a club/music magazine, contact with local organisations (youth programmes, student unions, sexual health clinics, gay outreach, offender and drug services), interviewer networks, snowball referrals, and paid gatekeepers who were limited in the number of referrals they could provide. The researchers deliberately did not recruit directly from clubs. Four trained interviewers (two female, two male) conducted interviews lasting about 1–2 hours. A research instrument was piloted on the first 12 respondents (who remained in the sample) and then used to guide discussion of first, last, and typical Ecstasy use, positive and negative experiences, drug-taking rituals, health issues, and sexual behaviour during episodes. Interviews were audio‑recorded, transcribed, and accompanied by a short demographic and drug-use history questionnaire completed at the end. Participants were assured of confidentiality and anonymity and were given a gift certificate for participation. The extracted text does not clearly report a formal analytic method (for example, a named coding or thematic analysis procedure) or whether analyses followed a specific qualitative framework; the paper presents participants' accounts and identifies recurrent themes.

Sample characteristics and drug use: The sample was predominantly male (69%), aged 17–45 years (mean = 25, median = 24), with 16% identifying as gay or bisexual. Social class was self-reported (49% working class, 46% middle class). Fifty-seven percent were employed. Ninety-two percent had used Ecstasy in the 6 months prior to interview; within that period 50% had used less than once a month and 37% had used one to four times per month. Approximately half had used Ecstasy within 2 weeks of interview, and 44% reported at least 100 lifetime Ecstasy episodes. Polydrug use was common: all respondents had tried cannabis (32% daily), 90% had used LSD/magic mushrooms, 93% amphetamines, 45% cocaine, and 11% heroin. Weekly alcohol consumption and heavy cigarette smoking were also frequently reported. Social setting and contexts of use: Participants described a range of settings for Ecstasy consumption, including clubs with techno/house music conducive to dancing, after‑parties and organised house parties, and small private gatherings among close friends. Many respondents reported consuming additional tablets at after‑hours parties; others preferred private settings for comfort and to manage comedowns. Although clubs were central to many users' experiences, the study did not recruit from club doorways or directly within clubs. Sensuality and emotional closeness: A slight majority described MDMA use as producing strong feelings of sensuality, empathy, and emotional closeness rather than an increased drive for penetrative sex. For many males this manifested as a desire to hold or be close to others rather than to pursue sexual liaisons; several female respondents echoed that MDMA made them feel "loved up" and more interested in emotional aspects than in penetrative sex. Dancing and shared affective experience frequently took precedence over sexual pursuit. Sexual arousal and function: The sample contained a distinct subgroup who reported marked increases in sexual desire and used MDMA as a sexual aid, including instances of prolonged sexual activity. However, sexual performance problems—particularly difficulty achieving or maintaining an erection and delayed ejaculation—were reported, especially among younger males (roughly those aged 25 and under). Participants emphasised variability: some individuals found sex on MDMA highly pleasurable and "different" (more affectionate), while others experienced little sexual interest or encountered functional difficulties. Reports also described MDMA facilitating exploration of new sexual behaviours; a small number of respondents, notably some gay and bisexual women, reported using MDMA specifically to enhance sexual encounters or to facilitate same‑sex exploration. Sexual risk behaviours: Among those who did engage in sex during MDMA episodes, risky behaviours were described. Younger respondents (about 18–25 years) were more likely to report multiple partners, one‑night stands with strangers or acquaintances, and next‑day regret about sexual encounters. Condom use during MDMA‑related intercourse was described as rare, and some participants reported using condoms with strangers but not with partners. Participants gave mixed views on whether MDMA or alcohol increased sexual risk most: some felt MDMA lowered barriers and increased risky action through a "love buzz," while others believed MDMA afforded more control than alcohol. The researchers noted that disentangling the effects of MDMA from alcohol and cannabis use was not possible in their data. Prevention and harm reduction observations: Respondents and the authors noted that condom machines existed in some clubs but placement and privacy problems limited uptake. The paper highlights outreach within clubs and peer education as potential harm reduction strategies, while recognising that many users consume MDMA in private residences and would require different outreach approaches.

Mcelrath interprets the findings as indicating two principal patterns of MDMA's relationship with sexuality: for many users MDMA heightens feelings of sensuality, empathy, and emotional closeness without necessarily increasing the desire for penetrative sex; for a distinct subgroup the drug enhances sexual desire and can be used intentionally as a sexual aid. The study also documents MDMA‑related sexual dysfunction (notably erectile difficulties among younger males) and substantial sexual risk taking among some users, characterised by multiple partners, encounters with acquaintances or strangers, and low condom use. These qualitative findings are presented as broadly consistent with prior literature that has reported both increased sensuality/empathy and impaired sexual performance under MDMA, as well as studies linking MDMA use with multiple partners and unprotected sex in some populations (including men who have sex with men). The authors emphasise that polydrug use and study design limitations in earlier work complicate causal interpretation, a limitation that also applies to the present study. Key limitations acknowledged by the authors include the age of the data (1997–1998) and likely subsequent changes in drug markets and club culture; non‑probability recruitment (including snowball and gatekeeper referrals) that limits generalisability; retrospective self‑report subject to recall bias; small subgroup sizes that prevent firm conclusions about groups such as gay and bisexual women; and an inability to disentangle interaction effects between MDMA, alcohol, and cannabis. The authors note that patterns observed in Northern Ireland at the time may not apply elsewhere or at later dates. For future research and practice, the paper calls for prospective designs and cross‑cultural comparisons to better understand temporal sequencing and contextual influences, studies that investigate interaction effects of MDMA with alcohol and cannabis on sexual behaviour, and targeted prevention/harm reduction measures such as proactive outreach in club settings and peer education for users who preferentially consume MDMA in private residences. The authors recommend further investigation of sexual behaviour among MDMA users in other countries, including the United States, to allow comparative analysis.